New heart valve device offers hope for patients with congenital defects
NCT ID NCT03441971
First seen Feb 05, 2026 · Last updated Apr 25, 2026 · Updated 10 times
Summary
This study is testing a new device called the GORE PV1 to replace the pulmonary valve and fix the right ventricular outflow tract in people with congenital heart defects like Tetralogy of Fallot. The study includes 15 participants aged 5 and older. The main goal is to see if the device is safe and works well at 6 months after the procedure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY VALVE INSUFFICIENCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
-
Lurie Children's Hospital
Chicago, Illinois, 60611, United States
-
Nationwide Children's Hospital
Columbus, Ohio, 43205, United States
Conditions
Explore the condition pages connected to this study.